{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:18:55Z","timestamp":1790360335624,"version":"4.1.0"},"reference-count":117,"publisher":"PAGEPress Publications","issue":"s1","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Histochem"],"abstract":"<jats:p>Sporadic Creutzfeldt-Jakob disease (sCJD) is a rare and fatal neurodegenerative disorder with an incidence of 1.5 to 2 cases per million population\/year. The disease is caused by a proteinaceous infectious agent, named prion (or PrPSc), which arises from the conformational conversion of the cellular prion protein (PrPC). Once formed, PrPSc interacts with the normally folded PrPC coercing it to undergo similar structural rearrangement. The disease is highly heterogeneous from a clinical and neuropathological point of view. The origin of this variability lies in the aberrant structures acquired by PrPSc. At least six different sCJD phenotypes have been described and each of them is thought to be caused by a peculiar PrPSc strain. Definitive sCJD diagnosis requires brain analysis with the aim of identifying intracerebral accumulation of PrPSc which currently represents the only reliable biomarker of the disease. Clinical diagnosis of sCJD is very challenging and is based on the combination of several clinical, instrumental and laboratory tests representing surrogate disease biomarkers. Thanks to the advent of the ultrasensitive Real-Time Quaking-Induced Conversion (RT-QuIC) assay, PrPSc was found in several peripheral tissues of sCJD patients, sometimes even before the clinical onset of the disease. This discovery represents an important step forward for the clinical diagnosis of sCJD. In this manuscript, we present an overview of the current applications and future perspectives of RT-QuIC in the field of sCJD diagnosis.<\/jats:p>","DOI":"10.4081\/ejh.2021.3298","type":"journal-article","created":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T06:58:17Z","timestamp":1634367497000},"source":"Crossref","is-referenced-by-count":15,"title":["Sporadic Creutzfeldt-Jakob disease: Real-Time Quaking Induced Conversion (RT-QuIC) assay represents a major diagnostic advance"],"prefix":"10.4081","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3744-7124","authenticated-orcid":false,"given":"Federico Angelo","family":"Cazzaniga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Bistaffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6233-8272","authenticated-orcid":false,"given":"Chiara Maria Giulia","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Bufano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Indaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-0802","authenticated-orcid":false,"given":"Giorgio","family":"Giaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2820-9880","authenticated-orcid":false,"given":"Fabio","family":"Moda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2549","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"3475","doi-asserted-by":"crossref","unstructured":"Ladogana A, Puopolo M, Croes EA, Budka H, Jarius C, Collins S, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 2005;64:1586\u201391.","DOI":"10.1212\/01.WNL.0000160117.56690.B2"},{"key":"3476","doi-asserted-by":"crossref","unstructured":"Imran M, Mahmood S. An overview of human prion diseases. Virol J 2011;8:559.","DOI":"10.1186\/1743-422X-8-559"},{"key":"3477","doi-asserted-by":"crossref","unstructured":"Heidenhain A. [Klinische und anatomische Untersuchungen \u00fcber eine eigenartige organische Erkrankung des Zentralnervensystems im Praesenium].[Article in German]. Z Gesamte Neurol Psy 1929;118:49\u2013114.","DOI":"10.1007\/BF02892896"},{"key":"3478","doi-asserted-by":"crossref","unstructured":"Mittal M, Hammond N, Husmann K, Lele A, Pasnoor M. Creutzfeldt-Jakob disease presenting as bulbar palsy. Muscle Nerve 2010;42:833\u20135.","DOI":"10.1002\/mus.21849"},{"key":"3479","unstructured":"Alema G, Bignami A. [Subacute degenerative presenile polioencephalopathy with akinetic stupor and decorticate rigidity with myoclonus (\u201cmyoclonic\u201d variety of the Jakob-Creutzfeld disease)].[Article in Italian]. Riv Sper Freniatr Med Leg Alien Ment 1959;83:S1485\u2013623."},{"key":"3480","unstructured":"Nowacki P, Kulczycki J, Narolewska A, Grzelec H. Amyotrophic form of Creutzfeldt-Jakob disease with rapid course in 82-year-old man. Folia Neuropathol 2000;38:161\u20133."},{"key":"3481","doi-asserted-by":"crossref","unstructured":"Stahl N. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 1987;51:229\u201340.","DOI":"10.1016\/0092-8674(87)90150-4"},{"key":"3482","doi-asserted-by":"crossref","unstructured":"Castle AR, Gill AC. Physiological functions of the cellular prion protein. Front Mol Biosci 2017;4:19.","DOI":"10.3389\/fmolb.2017.00019"},{"key":"3483","doi-asserted-by":"crossref","unstructured":"Turk E, Teplow DB, Hood LE, Prusiner SB. Purification and properties of the cellular and scrapie hamster prion proteins. Eur J Biochem 1988;176:21\u201330.","DOI":"10.1111\/j.1432-1033.1988.tb14246.x"},{"key":"3484","doi-asserted-by":"crossref","unstructured":"Caughey B, Race RE, Ernst D, Buchmeier MJ, Chesebro B. Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol 1989;63:175\u201381.","DOI":"10.1128\/jvi.63.1.175-181.1989"},{"key":"3485","doi-asserted-by":"crossref","unstructured":"Bate C, Nolan W, McHale-Owen H, Williams A. Sialic acid within the glycosylphosphatidylinositol anchor targets the cellular prion protein to synapses. J Biol Chem 2016;291:17093\u2013101.","DOI":"10.1074\/jbc.M116.731117"},{"key":"3486","doi-asserted-by":"crossref","unstructured":"Rudd PM, Endo T, Colominas C, Groth D, Wheeler SF, Harvey DJ, et al. Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc Natl Acad Sci USA 1999;96:13044\u20139.","DOI":"10.1073\/pnas.96.23.13044"},{"key":"3487","doi-asserted-by":"crossref","unstructured":"Oesch B, Westaway D, W\u00e4lchli M, McKinley MP, Kent SBH, Aebersold R, et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985;40:735\u201346.","DOI":"10.1016\/0092-8674(85)90333-2"},{"key":"3488","doi-asserted-by":"crossref","unstructured":"Parchi P, Strammiello R, Notari S, Giese A, Langeveld JPM, Ladogana A, et al. Incidence and spectrum of sporadic Creutzfeldt\u2013Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 2009;118:659\u201371.","DOI":"10.1007\/s00401-009-0585-1"},{"key":"3489","doi-asserted-by":"crossref","unstructured":"Soto C, Satani N. The intricate mechanisms of neurodegeneration in prion diseases. Trends Mol Med 2011;17:14\u201324.","DOI":"10.1016\/j.molmed.2010.09.001"},{"key":"3490","doi-asserted-by":"crossref","unstructured":"Prusiner SB. Prions. Proc Natl Acad Sci USA 1998;95:13363\u201383.","DOI":"10.1073\/pnas.95.23.13363"},{"key":"3491","doi-asserted-by":"crossref","unstructured":"Soto C. Diagnosing prion diseases: needs, challenges and hopes. Nat Rev Microbiol 2004;2:809\u201319.","DOI":"10.1038\/nrmicro1003"},{"key":"3492","doi-asserted-by":"crossref","unstructured":"Morales R, Hu PP, Duran-Aniotz C, Moda F, Diaz-Espinoza R, Chen B, et al. Strain-dependent profile of misfolded prion protein aggregates. Sci Rep 2016;6:20526.","DOI":"10.1038\/srep20526"},{"key":"3493","doi-asserted-by":"crossref","unstructured":"Rossi M, Baiardi S, Parchi P. Understanding prion strains: Evidence from studies of the disease forms affecting humans. Viruses 2019;11:309.","DOI":"10.3390\/v11040309"},{"key":"3494","doi-asserted-by":"crossref","unstructured":"Morales R, Abid K, Soto C. The prion strain phenomenon: Molecular basis and unprecedented features. Biochim Biophys Acta 2007;1772:681\u201391.","DOI":"10.1016\/j.bbadis.2006.12.006"},{"key":"3495","doi-asserted-by":"crossref","unstructured":"Zafar S, Younas N, Shafiq M, Zerr I. Prion protein strain diversity and disease pathology. in: prions - Some physiological and pathophysiological aspects IntechOpen; 2019.","DOI":"10.5772\/intechopen.80702"},{"key":"3496","doi-asserted-by":"crossref","unstructured":"Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224\u201333.","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W"},{"key":"3497","doi-asserted-by":"crossref","unstructured":"Hosszu LLP, Jackson GS, Trevitt CR, Jones S, Batchelor M, Bhelt D, et al. The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPc. J Biol Chem 2004; 279:28515-21.","DOI":"10.1074\/jbc.M313762200"},{"key":"3498","doi-asserted-by":"crossref","unstructured":"Safar JG. Molecular pathogenesis of sporadic prion diseases in man. Prion 2012;6:108\u201315.","DOI":"10.4161\/pri.18666"},{"key":"3499","doi-asserted-by":"crossref","unstructured":"Kobayashi A, Iwasaki Y, Otsuka H, Yamada M, Yoshida M, Matsuura Y, et al. Deciphering the pathogenesis of sporadic Creutzfeldt-Jakob disease with codon 129 M\/V and type 2 abnormal prion protein. Acta Neuropathol Commun 2013;1:74.","DOI":"10.1186\/2051-5960-1-74"},{"key":"3500","doi-asserted-by":"crossref","unstructured":"Kobayashi A, Teruya K, Matsuura Y, Shirai T, Nakamura Y, Yamada M, et al. The influence of PRNP polymorphisms on human prion disease susceptibility: an update. Acta Neuropathol 2015:130:159-70.","DOI":"10.1007\/s00401-015-1447-7"},{"key":"3501","doi-asserted-by":"crossref","unstructured":"Uro-Coste E, Cassard H, Simon S, Lugan S, Bilheude JM, Perret-Liaudet A, et al. Beyond PrPres type 1\/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog 2008;4:e1000029.","DOI":"10.1371\/journal.ppat.1000029"},{"key":"3502","doi-asserted-by":"crossref","unstructured":"Cassard H, Huor A, Espinosa JC, Douet JY, Lugan S, Aron N, et al. Prions from sporadic Creutzfeldt-Jakob disease patients propagate as strain mixtures. MBio 2020;11:e00393-20.","DOI":"10.1128\/mBio.00393-20"},{"key":"3503","doi-asserted-by":"crossref","unstructured":"Puoti G, Giaccone G, Rossi G, Canciani B, Bugiani O, Tagliavini F. Sporadic Creutzfeldt-Jakob disease: Co-occurrence of different types of PrPSc in the same brain. Neurology 1999;53:2173-6.","DOI":"10.1212\/WNL.53.9.2173"},{"key":"3504","doi-asserted-by":"crossref","unstructured":"Zerr I, Schulz\u2010Schaeffer WJ, Giese A, Bodemer M, Schr\u00f6ter A, Henkel K, et al. Current clinical diagnosis in Creutzfeldt\u2010Jakob disease: Identification of uncommon variants. Ann Neurol 2000;48:323-9.","DOI":"10.1002\/1531-8249(200009)48:3<323::AID-ANA6>3.0.CO;2-5"},{"key":"3505","doi-asserted-by":"crossref","unstructured":"Parchi P, de Boni L, Saverioni D, Cohen ML, Ferrer I, Gambetti P, et al. Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 2012;124:517\u201329.","DOI":"10.1007\/s00401-012-1002-8"},{"key":"3506","doi-asserted-by":"crossref","unstructured":"Collins SJ. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 2006;129:2278\u201387.","DOI":"10.1093\/brain\/awl159"},{"key":"3507","doi-asserted-by":"crossref","unstructured":"Baiardi S, Magherini A, Capellari S, Redaelli V, Ladogana A, Rossi M, et al. Towards an early clinical diagnosis of sporadic CJD VV2 (ataxic type). J Neurol Neurosurg Psychiatry 2017;88:764\u201372.","DOI":"10.1136\/jnnp-2017-315942"},{"key":"3508","doi-asserted-by":"crossref","unstructured":"Parchi P, Capellari S, Chin S, Schwarz HB, Schecter NP, Butts JD, et al. A subtype of sporadic prion disease mimicking fatal familial insomnia. Neurology 1999;52:1757-63.","DOI":"10.1212\/WNL.52.9.1757"},{"key":"3509","doi-asserted-by":"crossref","unstructured":"Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 2012;11:618\u201328.","DOI":"10.1016\/S1474-4422(12)70063-7"},{"key":"3510","doi-asserted-by":"crossref","unstructured":"Scaravilli F, Cordery RJ, Kretzschmar H, Gambetti P, Brink B, Fritz V, et al. Sporadic fatal insomnia: A case study. Ann Neurol 2000;48:665\u20139.","DOI":"10.1002\/1531-8249(200010)48:4<665::AID-ANA15>3.0.CO;2-D"},{"key":"3511","doi-asserted-by":"crossref","unstructured":"Krasnianski A, Meissner B, Schulz-Schaeffer W, Kallenberg K, Bartl M, Heinemann U, et al. Clinical features and diagnosis of the MM2 Cortical subtype of sporadic Creutzfeldt-Jakob disease. Arch Neurol 2006;63:876.","DOI":"10.1001\/archneur.63.6.876"},{"key":"3512","doi-asserted-by":"crossref","unstructured":"Mead S, Rudge P. CJD mimics and chameleons. Pract Neurol 2017;17:113\u201321.","DOI":"10.1136\/practneurol-2016-001571"},{"key":"3513","doi-asserted-by":"crossref","unstructured":"Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009;132:2659\u201368.","DOI":"10.1093\/brain\/awp191"},{"key":"3514","doi-asserted-by":"crossref","unstructured":"Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RSG, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000;55:811\u20135.","DOI":"10.1212\/WNL.55.6.811"},{"key":"3515","doi-asserted-by":"crossref","unstructured":"Collie DA, Sellar RJ, Zeidler M, Colchester ACF, Knight R, Will RG. MRI of Creutzfeldt\u2013Jakob disease: Imaging features and recommended MRI protocol. Clin Radiol 2001;56:726\u201339.","DOI":"10.1053\/crad.2001.0771"},{"key":"3516","doi-asserted-by":"crossref","unstructured":"Karch A, Zerr I. A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease. Neurology 2013;80:2081.","DOI":"10.1212\/01.wnl.0000431029.13491.59c"},{"key":"3517","doi-asserted-by":"crossref","unstructured":"Blennow K, Johansson A, Zetterberg H. Diagnostic value of 14-3-3\u03b2 immunoblot and T-tau\/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease. Int J Mol Med 2005;16:1147-9.","DOI":"10.3892\/ijmm.16.6.1147"},{"key":"3518","doi-asserted-by":"crossref","unstructured":"Coulthart MB, Jansen GH, Olsen E, Godal DL, Connolly T, Choi BCK, et al. Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study. BMC Neurol 2011;11:133.","DOI":"10.1186\/1471-2377-11-133"},{"key":"3519","doi-asserted-by":"crossref","unstructured":"Chohan G, Pennington C, Mackenzie JM, Andrews M, Everington D, Will RG, et al. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry 2010;81:1243\u20138.","DOI":"10.1136\/jnnp.2009.197962"},{"key":"3520","doi-asserted-by":"crossref","unstructured":"Bahl JMC, Heegaard NHH, Falkenhorst G, Laursen H, H\u00f8genhaven H, M\u00f8lbak K, et al. The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer\u2019s disease. Neurobiol Aging 2009;30:1834\u201341.","DOI":"10.1016\/j.neurobiolaging.2008.01.013"},{"key":"3521","doi-asserted-by":"crossref","unstructured":"Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Saanchez-Valle R, Mitrovaa E, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2006;67:637\u201343.","DOI":"10.1212\/01.wnl.0000230159.67128.00"},{"key":"3522","doi-asserted-by":"crossref","unstructured":"Stoeck K, Sanchez-Juan P, Gawinecka J, Green A, Ladogana A, Pocchiari M, et al. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt\u2013Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain 2012;135:3051\u201361.","DOI":"10.1093\/brain\/aws238"},{"key":"3523","doi-asserted-by":"crossref","unstructured":"Satoh J, Kurohara K, Yukitake M, Kuroda Y. The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture. Eur Neurol 1999;41:216\u201325.","DOI":"10.1159\/000008054"},{"key":"3524","doi-asserted-by":"crossref","unstructured":"Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998;43:32\u201340.","DOI":"10.1002\/ana.410430109"},{"key":"3525","doi-asserted-by":"crossref","unstructured":"Chapman T, McKeel DW, Morris JC. Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000;55:1396\u20138.","DOI":"10.1212\/WNL.55.9.1396"},{"key":"3526","doi-asserted-by":"crossref","unstructured":"Muayqil T, Gronseth G, Camicioli R. Evidence-based guideline: Diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2012;79:1499\u2013506.","DOI":"10.1212\/WNL.0b013e31826d5fc3"},{"key":"3527","doi-asserted-by":"crossref","unstructured":"Hamlin C, Puoti G, Berri S, Sting E, Harris C, Cohen M, et al. A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease. Neurology 2012;79:547\u201352.","DOI":"10.1212\/WNL.0b013e318263565f"},{"key":"3528","doi-asserted-by":"crossref","unstructured":"Forner SA, Takada LT, Bettcher BM, Lobach I V., Tartaglia MC, Torres-Chae C, et al. Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease. Neurol Clin Pract 2015;5:116\u201325.","DOI":"10.1212\/CPJ.0000000000000111"},{"key":"3529","doi-asserted-by":"crossref","unstructured":"Abu-Rumeileh S, Baiardi S, Polischi B, Mammana A, Franceschini A, Green A, et al. Diagnostic value of surrogate CSF biomarkers for Creutzfeldt\u2013Jakob disease in the era of RT-QuIC. J Neurol 2019;266:3136\u201343.","DOI":"10.1007\/s00415-019-09537-0"},{"key":"3530","doi-asserted-by":"crossref","unstructured":"Lattanzio F, Abu-Rumeileh S, Franceschini A, Kai H, Amore G, Poggiolini I, et al. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and A\u03b242 levels. Acta Neuropathol 2017;133:559\u201378.","DOI":"10.1007\/s00401-017-1683-0"},{"key":"3531","doi-asserted-by":"crossref","unstructured":"Blennow K, Diaz-Lucena D, Zetterberg H, Villar-Pique A, Karch A, Vidal E, et al. CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD. J Neurol Neurosurg Psychiatry 2019;90:846\u201353.","DOI":"10.1136\/jnnp-2018-320155"},{"key":"3532","doi-asserted-by":"crossref","unstructured":"Skillb\u00e4ck T, Ros\u00e9n C, Asztely F, Mattsson N, Blennow K, Zetterberg H. Diagnostic Performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease. JAMA Neurol 2014;71:476.","DOI":"10.1001\/jamaneurol.2013.6455"},{"key":"3533","doi-asserted-by":"crossref","unstructured":"Baldeiras IE, Ribeiro MH, Pacheco P, Machado \u00c1, Santana I, Cunha L, et al. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients. J Neurol 2009;256:1540\u201350.","DOI":"10.1007\/s00415-009-5160-0"},{"key":"3534","doi-asserted-by":"crossref","unstructured":"Skinningsrud A, Stenset V, Gundersen AS, Fladby T. Cerebrospinal fluid markers in Creutzfeldt-Jakob disease. Cerebrospinal Fluid Res 2008;5:14.","DOI":"10.1186\/1743-8454-5-14"},{"key":"3535","doi-asserted-by":"crossref","unstructured":"Kovacs GG, Andreasson U, Liman V, Regelsberger G, Lutz MI, Danics K, et al. Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort. Eur J Neurol 2017;24:1326-e77.","DOI":"10.1111\/ene.13389"},{"key":"3536","doi-asserted-by":"crossref","unstructured":"Zerr I, Schmitz M, Karch A, Villar-Piqu\u00e9 A, Kanata E, Golanska E, et al. Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases. Alzheimer\u2019s Dement 2018;14:751\u201363.","DOI":"10.1016\/j.jalz.2017.12.008"},{"key":"3537","doi-asserted-by":"crossref","unstructured":"Antonell A, Tort\u2010Merino A, R\u00edos J, Balasa M, Borrego\u2010\u00c9cija S, Auge JM, et al. Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias. Alzheimer\u2019s Dement 2020;16:262\u201372.","DOI":"10.1016\/j.jalz.2019.09.001"},{"key":"3538","doi-asserted-by":"crossref","unstructured":"Abu-Rumeileh S, Capellari S, Stanzani-Maserati M, Polischi B, Martinelli P, Caroppo P, et al. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias. Alzheimers Res Ther 2018;10:3.","DOI":"10.1186\/s13195-017-0331-1"},{"key":"3539","doi-asserted-by":"crossref","unstructured":"Kanata E, Golanska E, Villar-Piqu\u00e9 A, Karsanidou A, Dafou D, Xanthopoulos K, et al. Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease. J Clin Neurosci 2019;60:124\u20137.","DOI":"10.1016\/j.jocn.2018.09.031"},{"key":"3540","doi-asserted-by":"crossref","unstructured":"Steinacker P, Blennow K, Halbgebauer S, Shi S, Ruf V, Oeckl P, et al. Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease. Sci Rep 2016;6:38737.","DOI":"10.1038\/srep38737"},{"key":"3541","doi-asserted-by":"crossref","unstructured":"Thompson AGB, Luk C, Heslegrave AJ, Zetterberg H, Mead SH, Collinge J, et al. Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression. J Neurol Neurosurg Psychiatry 2018;89:955\u201361.","DOI":"10.1136\/jnnp-2017-317793"},{"key":"3542","doi-asserted-by":"crossref","unstructured":"Gao L, Tang H, Nie K, Wang L, Zhao J, Gan R, et al. Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson\u2019s disease diagnosis: a systematic review and meta-analysis. Int J Neurosci 2015;125:645\u201354.","DOI":"10.3109\/00207454.2014.961454"},{"key":"3543","doi-asserted-by":"crossref","unstructured":"Bousiges O, Philippi N, Lavaux T, Perret-Liaudet A, Lachmann I, Schaeffer-Agal\u00e8de C, et al. Differential diagnostic value of total alpha-synuclein assay in the cerebrospinal fluid between Alzheimer\u2019s disease and dementia with Lewy bodies from the prodromal stage. Alzheimers Res Ther 2020;12:120.","DOI":"10.1186\/s13195-020-00684-5"},{"key":"3544","doi-asserted-by":"crossref","unstructured":"Llorens F, Kruse N, Karch A, Schmitz M, Zafar S, Gotzmann N, et al. Validation of \u03b1-synuclein as a CSF biomarker for sporadic Creutzfeldt-Jakob disease. Mol Neurobiol 2018;55:2249\u201357.","DOI":"10.1007\/s12035-017-0479-5"},{"key":"3545","doi-asserted-by":"crossref","unstructured":"Llorens F, Kruse N, Schmitz M, Gotzmann N, Golanska E, Th\u00fcne K, et al. Evaluation of \u03b1-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases. Alzheimer\u2019s Dement 2017;13:710\u20139.","DOI":"10.1016\/j.jalz.2016.09.013"},{"key":"3546","doi-asserted-by":"crossref","unstructured":"Schmitz M, Villar-Piqu\u00e9 A, Llorens F, Gmitterov\u00e1 K, Hermann P, Varges D, et al. Cerebrospinal fluid total and phosphorylated \u03b1-synuclein in patients with Creutzfeldt\u2013Jakob disease and synucleinopathy. Mol Neurobiol 2019;56:3476\u201383.","DOI":"10.1007\/s12035-018-1313-4"},{"key":"3547","doi-asserted-by":"crossref","unstructured":"Aksamit AJ, Preissner CM, Homburger HA. Quantitation of 14-3-3 and neuron-specific enolase proteins in CSF in Creutzfeldt-Jakob disease. Neurology 2001;57:728\u201330.","DOI":"10.1212\/WNL.57.4.728"},{"key":"3548","doi-asserted-by":"crossref","unstructured":"Zerr I, Bodemer M, R\u00e4cker S, Grosche S, Poser S, Weber T, et al. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995;345:1609\u201310.","DOI":"10.1016\/S0140-6736(95)90118-3"},{"key":"3549","doi-asserted-by":"crossref","unstructured":"Otto M, Wiltfang J, Schutz E, Zerr I, Otto A, Pfahlberg A, et al. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study. BMJ 1998;316:577\u201382.","DOI":"10.1136\/bmj.316.7131.577"},{"key":"3550","doi-asserted-by":"crossref","unstructured":"Vanni S, Moda F, Zattoni M, Bistaffa E, De Cecco E, Rossi M, et al. Differential overexpression of SERPINA3 in human prion diseases. Sci Rep 2017;7:15637.","DOI":"10.1038\/s41598-017-15778-8"},{"key":"3551","doi-asserted-by":"crossref","unstructured":"Le Pera M, Urso E, Sprovieri T, Bossio S, Aguglia U, Manna I, et al. Contribution of cerebrospinal fluid thymosin \u03b24 levels to the clinical differentiation of Creutzfeldt-Jakob disease. Arch Neurol 2012;69:868-72.","DOI":"10.1001\/archneurol.2011.3558"},{"key":"3552","doi-asserted-by":"crossref","unstructured":"Barria MA, Libori A, Mitchell G, Head MW. Susceptibility of human prion protein to conversion by chronic wasting disease prions. Emerg Infect Dis 2018;24:1482\u20139.","DOI":"10.3201\/eid2408.161888"},{"key":"3553","doi-asserted-by":"crossref","unstructured":"Moda F, Gambetti P, Notari S, Concha-Marambio L, Catania M, Park K-W, et al. Prions in the urine of patients with variant Creutzfeldt\u2013Jakob disease. N Engl J Med 2014;371:530-9.","DOI":"10.1056\/NEJMoa1404401"},{"key":"3554","doi-asserted-by":"crossref","unstructured":"Concha-Marambio L, Pritzkow S, Moda F, Tagliavini F, Ironside JW, Schulz PE, et al. Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease. Sci Transl Med 2016;8:370ra183.","DOI":"10.1126\/scitranslmed.aaf6188"},{"key":"3555","doi-asserted-by":"crossref","unstructured":"B\u00e9londrade M, Nicot S, Mayran C, Bruyere-Ostells L, Almela F, Di Bari MA, et al. Sensitive protein misfolding cyclic amplification of sporadic Creutzfeldt\u2013Jakob disease prions is strongly seed and substrate dependent. Sci Rep 2021;11:4058.","DOI":"10.1038\/s41598-021-83630-1"},{"key":"3556","doi-asserted-by":"crossref","unstructured":"Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 2011;17:175-8.","DOI":"10.1038\/nm.2294"},{"key":"3557","doi-asserted-by":"crossref","unstructured":"Franceschini A, Baiardi S, Hughson AG, McKenzie N, Moda F, Rossi M, et al. High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions. Sci Rep 2017;7:10655.","DOI":"10.1038\/s41598-017-10922-w"},{"key":"3558","doi-asserted-by":"crossref","unstructured":"Orr\u00fa CD, Bongianni M, Tonoli G, Ferrari S, Hughson AG, Groveman BR, et al. A test for Creutzfeldt\u2013Jakob disease using nasal brushings. N Engl J Med 2014;371:519\u201329.","DOI":"10.1056\/NEJMoa1315200"},{"key":"3559","doi-asserted-by":"crossref","unstructured":"Mammana A, Baiardi S, Rossi M, Franceschini A, Donadio V, Capellari S, et al. Detection of prions in skin punch biopsies of Creutzfeldt-akob disease patients. Ann Clin Transl Neurol 2020;7:559\u201364.","DOI":"10.1002\/acn3.51000"},{"key":"3560","doi-asserted-by":"crossref","unstructured":"Cazzaniga FA, De Luca CMG, Bistaffa E, Consonni A, Legname G, Giaccone G, et al. Cell-free amplification of prions: Where do we stand? Prog Mol Biol Transl Sci 2020;175:325\u201358.","DOI":"10.1016\/bs.pmbts.2020.08.005"},{"key":"3561","doi-asserted-by":"crossref","unstructured":"Schmitz M, Cramm M, Llorens F, M\u00fcller-Cramm D, Collins S, Atarashi R, et al. The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases. Nat Protoc 2016;11:2233\u201342.","DOI":"10.1038\/nprot.2016.120"},{"key":"3562","doi-asserted-by":"crossref","unstructured":"McGuire LI, Peden AH, Orr\u00fa CD, Wilham JM, Appleford NE, Mallinson G, et al. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol 2012;72:278\u201385.","DOI":"10.1002\/ana.23589"},{"key":"3563","doi-asserted-by":"crossref","unstructured":"Orr\u00fa C, Hughson A, Groveman B, Campbell K, Anson K, Manca M, et al. Factors that improve RT-QuIC detection of prion seeding activity. Viruses 2016;8:140.","DOI":"10.3390\/v8050140"},{"key":"3564","doi-asserted-by":"crossref","unstructured":"Candelise N, Baiardi S, Franceschini A, Rossi M, Parchi P. Towards an improved early diagnosis of neurodegenerative diseases: the emerging role of in vitro conversion assays for protein amyloids. Acta Neuropathol Commun 2020;8:117.","DOI":"10.1186\/s40478-020-00990-x"},{"key":"3565","doi-asserted-by":"crossref","unstructured":"Shaked GM, Fridlander G, Meiner Z, Taraboulos A, Gabizon R. Protease-resistant and detergent-insoluble prion protein is not necessarily associated with prion infectivity. J Biol Chem 1999;274:17981\u20136.","DOI":"10.1074\/jbc.274.25.17981"},{"key":"3566","doi-asserted-by":"crossref","unstructured":"McGuire LI, Poleggi A, Poggiolini I, Suardi S, Grznarova K, Shi S, et al. Cerebrospinal fluid real-time quaking-induced conversion is a robust and reliable test for sporadic creutzfeldt-jakob disease: An international study. Ann Neurol 2016;80:160\u20135.","DOI":"10.1002\/ana.24679"},{"key":"3567","doi-asserted-by":"crossref","unstructured":"Cramm M, Schmitz M, Karch A, Mitrova E, Kuhn F, Schroeder B, et al. Stability and reproducibility underscore utility of RT-QuIC for diagnosis of Creutzfeldt-Jakob disease. Mol Neurobiol 2016;53:1896\u2013904.","DOI":"10.1007\/s12035-015-9133-2"},{"key":"3568","doi-asserted-by":"crossref","unstructured":"Groveman BR, Orr\u00fa CD, Hughson AG, Bongianni M, Fiorini M, Imperiale D, et al. Extended and direct evaluation of RT-QuIC assays for Creutzfeldt-Jakob disease diagnosis. Ann Clin Transl Neurol 2017;4:139\u201344.","DOI":"10.1002\/acn3.378"},{"key":"3569","doi-asserted-by":"crossref","unstructured":"Park J-H, Choi Y-G, Lee Y-J, Park S-J, Choi H-S, Choi K-C, et al. Real-Time Quaking-induced conversion analysis for the diagnosis of sporadic Creutzfeldt-Jakob disease in Korea. J Clin Neurol 2016;12:101.","DOI":"10.3988\/jcn.2016.12.1.101"},{"key":"3570","doi-asserted-by":"crossref","unstructured":"Bongianni M, Orr\u00f9 C, Groveman BR, Sacchetto L, Fiorini M, Tonoli G, et al. Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples. JAMA Neurol 2017;74:15-62.","DOI":"10.1001\/jamaneurol.2016.4614"},{"key":"3571","doi-asserted-by":"crossref","unstructured":"Rhoads DD, Wrona A, Foutz A, Blevins J, Glisic K, Person M, et al. Diagnosis of prion diseases by RT-QuIC results in improved surveillance. Neurology 2020;95:e1017\u201326.","DOI":"10.1212\/WNL.0000000000010086"},{"key":"3572","unstructured":"Xiao K, Yang XH, Zou WQ, Dong XP, Shi Q. Assessment of the sensitivity and specificity of the established real-time quaking-induced conversion (RT-QuIC) technique in Chinese CJD surveillance. Biomed Environ Sci 2020;33:620\u20132."},{"key":"3573","doi-asserted-by":"crossref","unstructured":"Orr\u00fa CD, Groveman BR, Foutz A, Bongianni M, Cardone F, McKenzie N, et al. Ring trial of 2nd generation RT\u2010QuIC diagnostic tests for sporadic CJD. Ann Clin Transl Neurol 2020;7:2262\u201371.","DOI":"10.1002\/acn3.51219"},{"key":"3574","doi-asserted-by":"crossref","unstructured":"Fiorini M, Iselle G, Perra D, Bongianni M, Capaldi S, Sacchetto L, et al. High diagnostic accuracy of RT-QuIC assay in a prospective study of patients with suspected sCJD. Int J Mol Sci 2020;21:880.","DOI":"10.3390\/ijms21030880"},{"key":"3575","doi-asserted-by":"crossref","unstructured":"Hermann P, Laux M, Glatzel M, Matschke J, Knipper T, Goebel S, et al. Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance. Neurology 2018;91:e331\u20138.","DOI":"10.1212\/WNL.0000000000005860"},{"key":"3576","doi-asserted-by":"crossref","unstructured":"Redaelli V, Bistaffa E, Zanusso G, Salzano G, Sacchetto L, Rossi M, et al. detection of prion seeding activity in the olfactory mucosa of patients with fatal familial insomnia. Sci Rep 2017;7:46269.","DOI":"10.1038\/srep46269"},{"key":"3577","doi-asserted-by":"crossref","unstructured":"Orr\u00fa CD, Groveman BR, Raymond LD, Hughson AG, Nonno R, Zou W, et al. Bank vole prion protein as an apparently universal substrate for RT-QuIC-based detection and discrimination of prion strains. Supattapone S, editor. PLoS Pathog 2015;11:e1004983.","DOI":"10.1371\/journal.ppat.1004983"},{"key":"3578","doi-asserted-by":"crossref","unstructured":"Bistaffa E, Vuong TT, Cazzaniga FA, Tran L, Salzano G, Legname G, et al. Use of different RT-QuIC substrates for detecting CWD prions in the brain of Norwegian cervids. Sci Rep 2019;9:18595.","DOI":"10.1038\/s41598-019-55078-x"},{"key":"3579","doi-asserted-by":"crossref","unstructured":"Orr\u00fa CD, Yuan J, Appleby BS, Li B, Li Y, Winner D, et al. Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease. Sci Transl Med 2017;9:eaam7785.","DOI":"10.1126\/scitranslmed.aam7785"},{"key":"3580","doi-asserted-by":"crossref","unstructured":"Orr\u00f9 CD, Soldau K, Cordano C, Llibre-Guerra J, Green AJ, Sanchez H, et al. Prion seeds distribute throughout the eyes of sporadic Creutzfeldt-Jakob disease patients. MBio 2018;9:e02095-18.","DOI":"10.1128\/mBio.02095-18"},{"key":"3581","doi-asserted-by":"crossref","unstructured":"Foutz A, Appleby BS, Hamlin C, Liu X, Yang S, Cohen Y, et al. Diagnostic and prognostic value of human prion detection in cerebrospinal fluid. Ann Neurol 2017;81:79\u201392.","DOI":"10.1002\/ana.24833"},{"key":"3582","doi-asserted-by":"crossref","unstructured":"Piconi G, Peden AH, Barria MA, Green AJE. Epitope mapping of the protease resistant products of RT-QuIC does not allow the discrimination of sCJD subtypes. PLoS One 2019;14:e0218509.","DOI":"10.1371\/journal.pone.0218509"},{"key":"3583","doi-asserted-by":"crossref","unstructured":"Hermann P, Appleby B, Brandel J-P, Caughey B, Collins S, Geschwind MD, et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol 2021;20:235-46.","DOI":"10.1016\/S1474-4422(20)30477-4"},{"key":"3584","doi-asserted-by":"crossref","unstructured":"Rudge P, Hyare H, Green A, Collinge J, Mead S. Imaging and CSF analyses effectively distinguish CJD from its mimics. J Neurol Neurosurg Psychiatry 2018;89:461\u20136.","DOI":"10.1136\/jnnp-2017-316853"},{"key":"3585","doi-asserted-by":"crossref","unstructured":"Hayashi Y, Iwasaki Y, Yoshikura N, Asano T, Mimuro M, Kimura A, et al. An autopsy-verified case of steroid-responsive encephalopathy with convulsion and a false-positive result from the real-time quaking-induced conversion assay. Prion 2017;11:284\u201392.","DOI":"10.1080\/19336896.2017.1345416"},{"key":"3586","doi-asserted-by":"crossref","unstructured":"Hoover CE, Davenport KA, Henderson DM, Pulscher LA, Mathiason CK, Zabel MD, et al. detection and quantification of cwd prions in fixed paraffin embedded tissues by real-time quaking-induced conversion. Sci Rep 2016;6:25098.","DOI":"10.1038\/srep25098"},{"key":"3587","doi-asserted-by":"crossref","unstructured":"Green AJE. RT-QuIC: a new test for sporadic CJD. Pract Neurol 2019;19:49\u201355.","DOI":"10.1136\/practneurol-2018-001935"},{"key":"3588","doi-asserted-by":"crossref","unstructured":"Cramm M, Schmitz M, Karch A, Zafar S, Varges D, Mitrova E, et al. Characteristic CSF prion seeding efficiency in humans with prion diseases. Mol Neurobiol 2015;51:396-405.","DOI":"10.1007\/s12035-014-8709-6"},{"key":"3589","doi-asserted-by":"crossref","unstructured":"Orr\u00fa CD, Groveman BR, Hughson AG, Zanusso G, Coulthart MB, Caughey B. Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid. MBio 2015;6:e02451-14.","DOI":"10.1128\/mBio.02451-14"},{"key":"3590","doi-asserted-by":"crossref","unstructured":"Baiardi S, Redaelli V, Ripellino P, Rossi M, Franceschini A, Moggio M, et al. Prion-related peripheral neuropathy in sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2019;90:424\u20137.","DOI":"10.1136\/jnnp-2018-319221"},{"key":"3591","doi-asserted-by":"crossref","unstructured":"Satoh K, Fuse T, Nonaka T, Dong T, Takao M, Nakagaki T, et al. Postmortem quantitative analysis of prion seeding activity in the digestive system. Molecules 2019;24:4601.","DOI":"10.3390\/molecules24244601"}],"container-title":["European Journal of Histochemistry"],"original-title":[],"link":[{"URL":"https:\/\/ejh.it\/index.php\/ejh\/article\/download\/3298\/3177","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ejh.it\/index.php\/ejh\/article\/download\/3298\/3177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T07:52:58Z","timestamp":1634370778000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejh.it\/index.php\/ejh\/article\/view\/3298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":117,"journal-issue":{"issue":"s1","published-online":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.4081\/ejh.2021.3298","relation":{},"ISSN":["2038-8306","1121-760X"],"issn-type":[{"value":"2038-8306","type":"electronic"},{"value":"1121-760X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,15]]}}}